Isoxazole
Based on 1 Customer Validation
Isoxazole is a member of the five-membered heterocycle drug scaffold. Isoxazole has been used as a BET bromodomain inhibitor and can improve β-cell function in a diabetic mouse model. Isoxazole and its derivatives exhibit broad biological activities (such as antimicrobial, antibacterial, antifungal, antiviral, anticancer, anti-inflammatory, immunomodulatory, analgesic, anti-tuberculosis, and anti-diabetic effects). For example, the bicyclic Isoxazole can act as an HSP90 inhibitor, and the tricyclic Isoxazole is promising as a selective multidrug resistance protein (MRP1) inhibitor.
For research use only. We do not sell to patients.
- Purity: 99.98%
- CAS No.: 288-14-2
- Formula: C3H3NO
- Molecular Weight:69.06
-
Storage:Pure form -20°C, 3 years ; In solvent -80°C, 6 months , -20°C, 1 month
All Antibiotic Isoforms
More
Biological Activity
|
Multidrug resistance proteins (MRPs) |
Isoxazole (20 µM, 48 hours) improves β-cell function by inhibiting excessive proliferation of MIN6 cells (mouse pancreatic β-cells) and altering the gene expression profile of MIN6 cells (enhancing the neuroendocrine phenotype)[5].
MedChemExpress (MCE) has not independently confirmed the accuracy of these methods. They are for reference only.
-
Cell Line:MIN6 mouse β-cell line
-
Concentration:20 µM
-
Incubation Time:48 h
-
Result:Significantly upregulates gene expression of STMN2.
-
Cell Line:MIN6 mouse β-cell line
-
Concentration:20 µM
-
Incubation Time:48 h
-
Result:Upregulates STMN2 protein expression.
-
Cell Line:INS1E mouse β-cell line
-
Concentration:20 µM
-
Incubation Time:72 h
-
Result:Reduced cell number, indicating inhibition of cell proliferation.
MedChemExpress (MCE) has not independently confirmed the accuracy of these methods. They are for reference only.
-
Animal Model:Diabetes model in PANIC-ATTAC mice induced by dimerizer (e.g., AP20187 (HY-13992))[5]
-
Dosage:16 mg/kg
-
Administration:Intraperitoneal injection (i.p.), once daily for 4 weeks
-
Result:Significant reduced blood glucose after oral glucose tolerance test (OGTT). Caused that pancreas insulin content increased approaching significance.
Chemical Information
-
CAS No. 288-14-2
-
Appearance Liquid (Density: 1.078 g/cm3)
-
Molecular Weight 69.06
-
Formula C3H3NO
-
Color Colorless to light yellow
-
SMILES
C1=CON=C1
-
Shipping
Room temperature in continental US; may vary elsewhere.
-
Storage
Pure form -20°C 3 years In solvent -80°C 6 months -20°C 1 month
Solvent & Solubility
DMSO : 100 mg/mL (1448.02 mM; Need ultrasonic; Hygroscopic DMSO has a significant impact on the solubility of product, please use newly opened DMSO)
Please refer to the solubility information to select the appropriate solvent. Once prepared, please aliquot and store the solution to prevent product inactivation from repeated freeze-thaw cycles.
Storage method and period of stock solution: -80°C, 6 months; -20°C, 1 month. When stored at -80°C, please use it within 6 months. When stored at -20°C, please use it within 1 month.
Please refer to the solubility information to select the appropriate solvent. Once prepared, please aliquot and store the solution to prevent product inactivation from repeated freeze-thaw cycles.
Storage method and period of stock solution: -80°C, 6 months; -20°C, 1 month. When stored at -80°C, please use it within 6 months. When stored at -20°C, please use it within 1 month.
Concentration (start) × Volume (start) = Concentration (final) × Volume (final)
Purity & Documentation
-
Data Sheet (285 KB)
-
SDS (466 KB)
- English - EN (466 KB)
- Français - FR (466 KB)
- Deutsch - DE (466 KB)
- Norwegian - NO (466 KB)
- Español - ES (466 KB)
- Swedish - SV (466 KB)
- Italian - IT (466 KB)
- Korean - KR (466 KB)
- Portuguese - PT (466 KB)
-
Handling Instructions (2659 KB)
References
[1]. Zhu J, et al. The recent progress of isoxazole in medicinal chemistry. Bioorg Med Chem. 2018 Jul 23;26(12):3065-3075. [Content Brief]
[2]. Sysak A, et al. Isoxazole ring as a useful scaffold in a search for new therapeutic agents. Eur J Med Chem. 2017 Sep 8;137:292-309. [Content Brief]
[3]. Norman BH, et al. Tricyclic isoxazoles are novel inhibitors of the multidrug resistance protein (MRP1)[J]. Bioorg Med Chem Lett. 2002 Mar 25;12(6):883-6. [Content Brief]
[4]. Agrawal N, Mishra P. The synthetic and therapeutic expedition of isoxazole and its analogs[J]. Med Chem Res. 2018;27(5):1309-1344. [Content Brief]
[5]. Kalwat MA, et al. Isoxazole Alters Metabolites and Gene Expression, Decreasing Proliferation and Promoting a Neuroendocrine Phenotype in β-Cells. ACS Chem Biol. 2016 Apr 15;11(4):1128-36. [Content Brief]
Complete Stock Solution Preparation Table
Please refer to the solubility information to select the appropriate solvent. Once prepared, please aliquot and store the solution to prevent product inactivation from repeated freeze-thaw cycles.
Storage method and period of stock solution: -80°C, 6 months; -20°C, 1 month. When stored at -80°C, please use it within 6 months. When stored at -20°C, please use it within 1 month.
| Optional Solvent | Concentration Solvent Mass | 1 mg | 5 mg | 10 mg | 25 mg |
|---|---|---|---|---|---|
| DMSO | 1 mM | 14.4802 mL | 72.4008 mL | 144.8016 mL | 362.0041 mL |
| 5 mM | 2.8960 mL | 14.4802 mL | 28.9603 mL | 72.4008 mL | |
| 10 mM | 1.4480 mL | 7.2401 mL | 14.4802 mL | 36.2004 mL | |
| 15 mM | 0.9653 mL | 4.8267 mL | 9.6534 mL | 24.1336 mL | |
| 20 mM | 0.7240 mL | 3.6200 mL | 7.2401 mL | 18.1002 mL | |
| 25 mM | 0.5792 mL | 2.8960 mL | 5.7921 mL | 14.4802 mL | |
| 30 mM | 0.4827 mL | 2.4134 mL | 4.8267 mL | 12.0668 mL | |
| 40 mM | 0.3620 mL | 1.8100 mL | 3.6200 mL | 9.0501 mL | |
| 50 mM | 0.2896 mL | 1.4480 mL | 2.8960 mL | 7.2401 mL | |
| 60 mM | 0.2413 mL | 1.2067 mL | 2.4134 mL | 6.0334 mL | |
| 80 mM | 0.1810 mL | 0.9050 mL | 1.8100 mL | 4.5251 mL | |
| 100 mM | 0.1448 mL | 0.7240 mL | 1.4480 mL | 3.6200 mL |